Nijmegen Centre for Molecular Life Sciences Applies Genomatix NextGen Sequencing Data Analysis
News Oct 20, 2009
Genomatix Software, the leading provider of solutions for the comprehensive analysis of Next Generation Sequencing (NGS) data, announced today that the Nijmegen Centre for Molecular Life Sciences (NCMLS) installed a Genomatix Genome Analyzer (GGA) at Henk Stunnenberg´s lab. Henk Stunnenberg, a pioneer in transcription factor analysis and epigenetic research, is full professor, head of the Department of Molecular Biology, and a member of EMBO.
The Genomatix Genome Analyzer delivers a complete and integrated solution for the downstream analysis of NGS data. Rich biological background knowledge, integrated in databases and comprehensive software tools, enable a molecular level understanding of the biology being studied within a few hours.
“The GGA has the advantage of incorporating all of the renowned software and data content Genomatix has built over the past 11 years, and putting an excellent NGS overlay on it all“ says Prof.Dr.Henk Stunnenberg. ”This allows us to drill down into the biology of our systems in an easy to use workflow environment with all their terrific science in the background”.
Martin Seifert Chief Executive for Marketing and Consulting at Genomatix says: “I am very proud that Dr. Stunnenberg has chosen our system. With our combined hardware/software approach, we are able to get the most out of data from Next Generation Sequencing experiments in surprisingly short time. Especially in the field of ChIP-Seq and RNA sequencing. Thus, shortening the time to publication significantly. For Dr. Stunnenberg´s group, with its many brilliant scientists, our integrated systems are greatly facilitating their data analysis process. We are very pleased that the response from the group is very positive, and their feedback will contribute substantially in helping to define the direction of further developments of our technology at Genomatix”.
The Nijmegen Centre for Molecular Life Sciences (NCMLS) is a leading multidisciplinary research school within the domain of molecular mechanisms of disease and particularly in the fields of molecular medicine, cell biology and translational research. The research is focused in keeping with the mission towards understanding the cellular basis of disease. Henk Stunnenberg´s research interest is in the unraveling of the molecular basis of cell behaviour emanating from the genetic and epigenetic code contained in the nucleus in the context of health and disease
Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone TumorsNews
The first genetic marker for the bone tumor, osteoblastoma, has been discovered. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment.READ MORE
Improved Method for Isolating Extracellular RNANews
In a breakthrough that could lead to powerful new ways to diagnose and track a wide range of medical conditions, scientists at The Rockefeller University have devised an improved method for isolating and identifying tiny fragments of RNA in human blood products.READ MORE
Giant Viruses Invent Their Own GenesNews
Three new members have been isolated and added to the Pandoravirus family. This strange family of viruses, with their giant genomes and many genes with no known equivalents, surprised scientists when they were discovered a few years ago. This new study notes that pandoraviruses appear to be factories for new genes – and therefore new functions.